Corbus Pharmaceuticals Holdings's three largest insider shareholders as of September 09, 2026 are Asset Management, Lp Cormorant (TenPercentOwner, 2.38Mn shares), Asset Management, Lp Cormorant (TenPercentOwner, 2.38Mn shares), Asset Management, Lp Cormorant (TenPercentOwner, 2.38Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Asset Management, Lp Cormorant | TenPercentOwner | 0 | 2,344,971 | 2,344,971 | 79.1% | 15 Dec, 2025 |
| 2 | Yuval Cohen | Chief Executive Officer | 164,495 | 0 | 164,495 | 5.5% | 10 Aug, 2026 |
| 3 | Sean F. Moran | Chief Financial Officer | 133,299 | 0 | 133,299 | 4.5% | 10 Aug, 2026 |
| 4 | Dominic Smethurst | Chief Medical Officer | 89,790 | 0 | 89,790 | 3.0% | 04 Mar, 2026 |
| 5 | Nishant C Saxena | Chief Business Officer | 77,900 | 0 | 77,900 | 2.6% | 12 Aug, 2026 |
| 6 | Ian Hodgson | Chief Operating Officer | 51,080 | 0 | 51,080 | 1.7% | 18 Feb, 2026 |
| 7 | Craig Stuart Millian | Chief Operating Officer | 27,000 | 0 | 27,000 | 0.9% | 12 Aug, 2022 |
| 8 | Winston Kung | Director | 14,166 | 0 | 14,166 | 0.5% | 21 May, 2026 |
| 9 | Alan F Holmer | Director | 12,008 | 0 | 12,008 | 0.4% | 02 Jun, 2025 |
| 10 | Rachelle Suzanne Jacques | Director | 11,383 | 0 | 11,383 | 0.4% | 21 May, 2026 |
| 11 | Yong Ben | Director | 11,383 | 0 | 11,383 | 0.4% | 21 May, 2026 |
| 12 | Anne Altmeyer | Director | 9,991 | 0 | 9,991 | 0.3% | 21 May, 2026 |
| 13 | Brent Pfeiffenberger | Director | 7,500 | 0 | 7,500 | 0.3% | 21 May, 2026 |
| 14 | Avery W Catlin | Director | 4,350 | 0 | 4,350 | 0.1% | 03 Jun, 2024 |
| 15 | John Kenneth Jenkins | Director | 3,833 | 0 | 3,833 | 0.1% | 11 Jun, 2026 |
| 16 | Peter Salzmann | Director | 2,783 | 0 | 2,783 | 0.1% | 03 Jun, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 11 Aug, 2026 | Nishant C Saxena | Chief Business Officer | Acquired P | 2,600 | $9.63 | $25.04K | 77,900 | Direct |
| 07 Aug, 2026 | Sean F. Moran | Chief Financial Officer | Disposed S | 12,000 | $10.08 | $120.97K | 84,694 | Direct |
| 07 Aug, 2026 | Yuval Cohen | Chief Executive Officer | Disposed S | 17,000 | $10.08 | $171.40K | 157,316 | Direct |
| 10 Jun, 2026 | John Kenneth Jenkins | Director | Disposed S | 4,800 | $7.91 | $37.99K | 3,833 | Direct |
| 02 Jun, 2026 | Nishant C Saxena | Chief Business Officer | Acquired P | 4,500 | $7.33 | $33.00K | 66,300 | Direct |
| 03 Jun, 2026 | Nishant C Saxena | Chief Business Officer | Acquired P | 9,000 | $7.58 | $68.22K | 75,300 | Direct |
| 21 May, 2026 | Nishant C Saxena | Chief Business Officer | Acquired A | 58,300 | $0.00 | $0 | 61,800 | Direct |
| 21 May, 2026 | Nishant C Saxena | Chief Business Officer | Acquired A | 192,300 | $0.00 | $0 | 192,300 | Direct |
| 19 May, 2026 | Rachelle Suzanne Jacques | Director | Acquired A | 3,800 | $0.00 | $0 | 11,383 | Direct |
| 19 May, 2026 | Anne Altmeyer | Director | Acquired A | 3,800 | $0.00 | $0 | 9,991 | Direct |
| 19 May, 2026 | John Kenneth Jenkins | Director | Acquired A | 3,800 | $0.00 | $0 | 8,633 | Direct |
| 19 May, 2026 | Winston Kung | Director | Acquired A | 3,800 | $0.00 | $0 | 14,166 | Direct |
| 19 May, 2026 | Brent Pfeiffenberger | Director | Acquired A | 7,500 | $0.00 | $0 | 7,500 | Direct |
| 19 May, 2026 | Yong Ben | Director | Acquired A | 3,800 | $0.00 | $0 | 11,383 | Direct |
| 19 May, 2026 | Rachelle Suzanne Jacques | Director | Acquired A | 12,300 | $0.00 | $0 | 12,300 | Direct |
| 19 May, 2026 | Yong Ben | Director | Acquired A | 12,300 | $0.00 | $0 | 12,300 | Direct |
| 19 May, 2026 | Winston Kung | Director | Acquired A | 12,300 | $0.00 | $0 | 12,300 | Direct |
| 19 May, 2026 | John Kenneth Jenkins | Director | Acquired A | 12,300 | $0.00 | $0 | 12,300 | Direct |
| 19 May, 2026 | Brent Pfeiffenberger | Director | Acquired A | 24,700 | $0.00 | $0 | 24,700 | Direct |
| 19 May, 2026 | Anne Altmeyer | Director | Acquired A | 12,300 | $0.00 | $0 | 12,300 | Direct |